Dexamethasone 700microgram intravitreal implant with device
NHS hospitals in England used £17,319,090 of indicative cost of Dexamethasone 700microgram intravitreal implant with device in the 12 months to July 2026, about 0.1% of all hospital medicines spend. That is up 2.5% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Dexamethasone 700microgram intravitreal implant with device: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Dexamethasone 700microgram intravitreal implant with device most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Moorfields Eye Hospital Nhs Ft | £1,649,520 |
| Maidstone And Tunbridge Wells Nhs Trust | £508,080 |
| Sheffield Teaching Hospitals Nhs Trust | £483,720 |
| Aintree University Hospital Nhs Ft | £468,060 |
| North West Anglia Nhs Foundation Trust | £456,750 |
| Univ Hpl B/Ham Nhs Foundation Trust | £371,490 |
| Univ Hpls Bristol Nhs Foundation Trust | £361,920 |
| Gloucestershire Hpls Nhs Foundation Trst | £346,260 |
| Colchester Hospital University Nhs Ft | £333,210 |
| University Hospitals Plymouth Nhs Trust | £324,510 |
The primary-care picture
Dexamethasone is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Dexamethasone medicine page.